ProImmune and the Roslin Institute Collaborate to Advance Animal Health Science
ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh’s Roslin Institute to advance veterinary immunology research through development and validation of novel species-specific Ankyron® binders. Increased understanding of animal health through the application of ProImmune’s proprietary Ankyron binding technology will enable development of new strategies for prevention, control, and diagnosis, of both veterinary and zoonotic diseases, overcoming challenges associated with the limited availability of high-quality, species-specific research reagents.
ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges
ProImmune Ltd, a global leader in immunological reagents and services, announced the launch of Mastering Immunity 2026 – Shanghai, an inaugural symposium in China providing practical, real-world guidance to help drug developers manage immunogenicity risk. Taking place at the Oriental Riverside Hotel in Shanghai, the event will convene leading scientists, industry executives, and regulatory professionals from around the world.
ProImmune Ltd Introduces ProVE® SL Self‑Loading MHC Class I Monomers to Improve T Cell Research Flexibility
ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ T cell detection are designed to offer researchers unprecedented flexibility, speed, and MHC allele-coverage, with over 50 HLA alleles available.
